Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 1420

1.

National Trends in Primary Care Visit Use and Practice Capabilities, 2008-2015.

Rao A, Shi Z, Ray KN, Mehrotra A, Ganguli I.

Ann Fam Med. 2019 Nov;17(6):538-544. doi: 10.1370/afm.2474.

2.

Alirocumab therapy in individuals with type 2 diabetes mellitus and atherosclerotic cardiovascular disease: analysis of the ODYSSEY DM-DYSLIPIDEMIA and DM-INSULIN studies.

Ray KK, Del Prato S, Müller-Wieland D, Cariou B, Colhoun HM, Tinahones FJ, Domenger C, Letierce A, Mandel J, Samuel R, Bujas-Bobanovic M, Leiter LA.

Cardiovasc Diabetol. 2019 Nov 9;18(1):149. doi: 10.1186/s12933-019-0951-9.

3.

Unscheduled Referrals and Unattended Appointments After Pediatric Subspecialty Referral.

Bohnhoff JC, Taormina JM, Ferrante L, Wolfson D, Ray KN.

Pediatrics. 2019 Nov 8. pii: e20190545. doi: 10.1542/peds.2019-0545. [Epub ahead of print]

PMID:
31704770
4.

Clues to cirrhosis - a focus on fibrosis.

Ray K.

Nat Rev Gastroenterol Hepatol. 2019 Oct 24. doi: 10.1038/s41575-019-0232-9. [Epub ahead of print] No abstract available.

PMID:
31649342
5.

Safety of the transventricular approach to deep brain stimulation: A retrospective review.

Ray K, Krel M, Bernstein J, Kashyap S, Ananda A.

Surg Neurol Int. 2019 Oct 4;10:192. doi: 10.25259/SNI_244_2019. eCollection 2019.

6.

High-throughput sequencing of pooled samples to determine community-level microbiome diversity.

Ray KJ, Cotter SY, Arzika AM, Kim J, Boubacar N, Zhou Z, Zhong L, Porco TC, Keenan JD, Lietman TM, Doan T.

Ann Epidemiol. 2019 Sep 20. pii: S1047-2797(18)30975-X. doi: 10.1016/j.annepidem.2019.09.002. [Epub ahead of print]

PMID:
31635933
7.

Infections in Deep Brain Stimulator Surgery.

Bernstein JE, Kashyap S, Ray K, Ananda A.

Cureus. 2019 Aug 20;11(8):e5440. doi: 10.7759/cureus.5440.

8.

Effects of Renal Impairment on the Pharmacokinetics, Efficacy, and Safety of Inclisiran: An Analysis of the ORION-7 and ORION-1 Studies.

Wright RS, Collins MG, Stoekenbroek RM, Robson R, Wijngaard PLJ, Landmesser U, Leiter LA, Kastelein JJP, Ray KK, Kallend D.

Mayo Clin Proc. 2019 Oct 17. pii: S0025-6196(19)30756-6. doi: 10.1016/j.mayocp.2019.08.021. [Epub ahead of print]

PMID:
31630870
9.

Feasibility and Effectiveness of Telelactation among Rural Breastfeeding Women.

Uscher-Pines L, Ghosh-Dastidar B, Bogen DL, Ray KN, Demirci JR, Mehrotra A, Kapinos KA.

Acad Pediatr. 2019 Oct 16. pii: S1876-2859(19)30434-6. doi: 10.1016/j.acap.2019.10.008. [Epub ahead of print]

PMID:
31629118
10.

Cross-Linking-Assisted Infection Reduction: A Randomized Clinical Trial Evaluating the Effect of Adjuvant Cross-Linking on Outcomes in Fungal Keratitis.

Prajna NV, Radhakrishnan N, Lalitha P, Austin A, Ray KJ, Keenan JD, Porco TC, Lietman TM, Rose-Nussbaumer J.

Ophthalmology. 2019 Sep 4. pii: S0161-6420(19)31960-8. doi: 10.1016/j.ophtha.2019.08.029. [Epub ahead of print]

PMID:
31619359
11.

Rare dyslipidaemias, from phenotype to genotype to management: a European Atherosclerosis Society task force consensus statement.

Hegele RA, Borén J, Ginsberg HN, Arca M, Averna M, Binder CJ, Calabresi L, Chapman MJ, Cuchel M, von Eckardstein A, Frikke-Schmidt R, Gaudet D, Hovingh GK, Kronenberg F, Lütjohann D, Parhofer KG, Raal FJ, Ray KK, Remaley AT, Stock JK, Stroes ES, Tokgözoğlu L, Catapano AL.

Lancet Diabetes Endocrinol. 2019 Sep 30. pii: S2213-8587(19)30264-5. doi: 10.1016/S2213-8587(19)30264-5. [Epub ahead of print] Review.

PMID:
31582260
12.

Stoichiometric Analyses of Soluble CD4 to Native-like HIV-1 Envelope by Single-Molecule Fluorescence Spectroscopy.

Agrawal P, DeVico AL, Foulke JS Jr, Lewis GK, Pazgier M, Ray K.

Cell Rep. 2019 Oct 1;29(1):176-186.e4. doi: 10.1016/j.celrep.2019.08.074.

13.

Oral Anti-Tumour Necrosis Factor Domain Antibody V565 Provides High Intestinal Concentrations, and Reduces Markers of Inflammation in Ulcerative Colitis Patients.

Nurbhai S, Roberts KJ, Carlton TM, Maggiore L, Cubitt MF, Ray KP, Reckless J, Mohammed H, Irving P, MacDonald TT, Vossenkämper A, West MR, Parkes GC, Crowe JS.

Sci Rep. 2019 Oct 1;9(1):14042. doi: 10.1038/s41598-019-50545-x.

14.

Circadian neuroimmune circuits influence intestinal physiology.

Ray K.

Nat Rev Gastroenterol Hepatol. 2019 Nov;16(11):648-649. doi: 10.1038/s41575-019-0220-0. No abstract available.

PMID:
31570807
15.

Apabetalone lowers serum alkaline phosphatase and improves cardiovascular risk in patients with cardiovascular disease.

Haarhaus M, Ray KK, Nicholls SJ, Schwartz GG, Kulikowski E, Johansson JO, Sweeney M, Halliday C, Lebioda K, Wong N, Brandenburg V, Beddhu S, Tonelli M, Zoccali C, Kalantar-Zadeh K.

Atherosclerosis. 2019 Nov;290:59-65. doi: 10.1016/j.atherosclerosis.2019.09.002. Epub 2019 Sep 17.

16.

Effect of 1 or 2 Doses of Inclisiran on Low-Density Lipoprotein Cholesterol Levels: One-Year Follow-up of the ORION-1 Randomized Clinical Trial.

Ray KK, Stoekenbroek RM, Kallend D, Nishikido T, Leiter LA, Landmesser U, Wright RS, Wijngaard PLJ, Kastelein JJP.

JAMA Cardiol. 2019 Sep 25. doi: 10.1001/jamacardio.2019.3502. [Epub ahead of print]

PMID:
31553410
17.

An Investigation of Exposure Control Methods With Variable-Length CAT Using the Partial Credit Model.

Leroux AJ, Waid-Ebbs JK, Wen PS, Helmer DA, Graham DP, O'Connor MK, Ray K.

Appl Psychol Meas. 2019 Nov;43(8):624-638. doi: 10.1177/0146621618824856. Epub 2019 Jan 23.

PMID:
31551640
18.

Intersectionality and Power Imbalances Clinicians of Color Face When Patients Request White Clinicians.

Ray KS.

Am J Bioeth. 2019 Feb;19(2):25-26. doi: 10.1080/15265161.2018.1557292. No abstract available.

PMID:
31543021
19.

Effect of selective BET protein inhibitor apabetalone on cardiovascular outcomes in patients with acute coronary syndrome and diabetes: Rationale, design, and baseline characteristics of the BETonMACE trial.

Ray KK, Nicholls SJ, Ginsberg HD, Johansson JO, Kalantar-Zadeh K, Kulikowski E, Toth PP, Wong N, Cummings JL, Sweeney M, Schwartz GG.

Am Heart J. 2019 Nov;217:72-83. doi: 10.1016/j.ahj.2019.08.001. Epub 2019 Aug 9.

PMID:
31520897
20.

Omomyc Reveals New Mechanisms To Inhibit the MYC Oncogene.

Demma MJ, Mapelli C, Sun A, Bodea S, Ruprecht B, Javaid S, Wiswell D, Muise E, Chen S, Zelina J, Orvieto F, Santoprete A, Altezza S, Tucci F, Escandon E, Hall B, Ray K, Walji A, O'Neil J.

Mol Cell Biol. 2019 Oct 28;39(22). pii: e00248-19. doi: 10.1128/MCB.00248-19. Print 2019 Nov 15.

21.

Ticagrelor in patients with diabetes and stable coronary artery disease with a history of previous percutaneous coronary intervention (THEMIS-PCI): a phase 3, placebo-controlled, randomised trial.

Bhatt DL, Steg PG, Mehta SR, Leiter LA, Simon T, Fox K, Held C, Andersson M, Himmelmann A, Ridderstråle W, Chen J, Song Y, Diaz R, Goto S, James SK, Ray KK, Parkhomenko AN, Kosiborod MN, McGuire DK, Harrington RA; THEMIS Steering Committee and Investigators.

Lancet. 2019 Sep 28;394(10204):1169-1180. doi: 10.1016/S0140-6736(19)31887-2. Epub 2019 Sep 1.

22.

The Use of and Experiences With Telelactation Among Rural Breastfeeding Mothers: Secondary Analysis of a Randomized Controlled Trial.

Kapinos K, Kotzias V, Bogen D, Ray K, Demirci J, Rigas MA, Uscher-Pines L.

J Med Internet Res. 2019 Sep 3;21(9):e13967. doi: 10.2196/13967.

23.

Association of Genetic Variants Related to Combined Exposure to Lower Low-Density Lipoproteins and Lower Systolic Blood Pressure With Lifetime Risk of Cardiovascular Disease.

Ference BA, Bhatt DL, Catapano AL, Packard CJ, Graham I, Kaptoge S, Ference TB, Guo Q, Laufs U, Ruff CT, Cupido A, Hovingh GK, Danesh J, Holmes MV, Smith GD, Ray KK, Nicholls SJ, Sabatine MS.

JAMA. 2019 Sep 2. doi: 10.1001/jama.2019.14120. [Epub ahead of print]

PMID:
31475726
24.

Insights on heterogeneity in blinking mechanisms and non-ergodicity using sub-ensemble statistical analysis of single quantum-dots.

Mukherjee A, Ray KK, Phadnis C, Layek A, Bera S, Chowdhury A.

J Chem Phys. 2019 Aug 28;151(8):084701. doi: 10.1063/1.5095870.

PMID:
31470698
25.

Closing in on C. difficile infection.

Ray K.

Nat Rev Gastroenterol Hepatol. 2019 Oct;16(10):581. doi: 10.1038/s41575-019-0206-y. No abstract available.

PMID:
31467436
26.

Targeting the peptidase PCSK9 to reduce cardiovascular risk: Implications for basic science and upcoming challenges.

Nishikido T, Ray KK.

Br J Pharmacol. 2019 Aug 29. doi: 10.1111/bph.14851. [Epub ahead of print] Review.

PMID:
31465540
27.

Pharmacological lipid-modification therapies for prevention of ischaemic heart disease: current and future options.

Ray KK, Corral P, Morales E, Nicholls SJ.

Lancet. 2019 Aug 24;394(10199):697-708. doi: 10.1016/S0140-6736(19)31950-6. Review.

28.

The HIV-1 Antisense Protein ASP Is a Transmembrane Protein of the Cell Surface and an Integral Protein of the Viral Envelope.

Affram Y, Zapata JC, Gholizadeh Z, Tolbert WD, Zhou W, Iglesias-Ussel MD, Pazgier M, Ray K, Latinovic OS, Romerio F.

J Virol. 2019 Oct 15;93(21). pii: e00574-19. doi: 10.1128/JVI.00574-19. Print 2019 Nov 1.

PMID:
31434734
29.

Preventing the development of hepatitis C in uninfected transplant recipients.

Ray K.

Nat Rev Gastroenterol Hepatol. 2019 Oct;16(10):582. doi: 10.1038/s41575-019-0203-1. No abstract available.

PMID:
31431730
30.

Increasing survival in HCV-related hepatocellular carcinoma.

Ray K.

Nat Rev Gastroenterol Hepatol. 2019 Oct;16(10):582. doi: 10.1038/s41575-019-0202-2. No abstract available.

PMID:
31431729
31.

PITCHing ursodeoxycholic acid in intrahepatic cholestasis of pregnancy versus placebo.

Ray K.

Nat Rev Gastroenterol Hepatol. 2019 Oct;16(10):582. doi: 10.1038/s41575-019-0201-3. No abstract available.

PMID:
31431728
32.

Every person is an individual: physical therapist clinical reasoning used in inpatient rehabilitation for walking assistive device prescription in patients with stroke and brain injury.

O'Brien SR, Durr K, Laubisch E, Losi L, Parrillo V, Pericozzi S, Poirier B, Poirier L, Ray K, Sackett A, Simoneau D.

Disabil Rehabil Assist Technol. 2019 Aug 20:1-8. doi: 10.1080/17483107.2019.1647568. [Epub ahead of print]

PMID:
31429328
33.

The structural dynamics of the kinesin-2 stalk heterodimer and its biological relevance.

Ahmed Z, Doodhi H, Bhaumik A, Mazumdar S, Ray K.

Biochem Biophys Res Commun. 2019 Oct 8;518(1):171-177. doi: 10.1016/j.bbrc.2019.08.026. Epub 2019 Aug 14.

PMID:
31420166
34.

Complement activation sustains neuroinflammation and deteriorates adult neurogenesis and spatial memory impairment in rat hippocampus following sleep deprivation.

Wadhwa M, Prabhakar A, Anand JP, Ray K, Prasad D, Kumar B, Panjwani U.

Brain Behav Immun. 2019 Nov;82:129-144. doi: 10.1016/j.bbi.2019.08.004. Epub 2019 Aug 10.

PMID:
31408672
35.

Connected Subspecialty Care: Applying Telehealth Strategies to Specific Referral Barriers.

Ray KN, Kahn JM.

Acad Pediatr. 2019 Aug 9. pii: S1876-2859(19)30369-9. doi: 10.1016/j.acap.2019.08.002. [Epub ahead of print] Review.

PMID:
31404707
36.

A viral small terminase subunit (TerS) twin ring pac synapsis DNA packaging model is supported by fluorescent fusion proteins.

Dixit AB, Ray K, Black LW.

Virology. 2019 Oct;536:39-48. doi: 10.1016/j.virol.2019.07.021. Epub 2019 Jul 25.

PMID:
31400548
37.

Authors' Response.

Ray KN, Uscher-Pines L, Mehrotra A.

Pediatrics. 2019 Aug;144(2). pii: e20191786C. doi: 10.1542/peds.2019-1786C. No abstract available.

PMID:
31371527
38.

Mapping the cells in the liver - unchartered subtypes and heterogeneity.

Ray K.

Nat Rev Gastroenterol Hepatol. 2019 Sep;16(9):513. doi: 10.1038/s41575-019-0192-0. No abstract available.

PMID:
31363179
39.

Bempedoic acid plus ezetimibe fixed-dose combination in patients with hypercholesterolemia and high CVD risk treated with maximally tolerated statin therapy.

Ballantyne CM, Laufs U, Ray KK, Leiter LA, Bays HE, Goldberg AC, Stroes ES, MacDougall D, Zhao X, Catapano AL.

Eur J Prev Cardiol. 2019 Jul 29:2047487319864671. doi: 10.1177/2047487319864671. [Epub ahead of print]

40.

Associations between lower levels of low-density lipoprotein cholesterol and cardiovascular events in very high-risk patients: Pooled analysis of nine ODYSSEY trials of alirocumab versus control.

Vallejo-Vaz AJ, Ray KK, Ginsberg HN, Davidson MH, Eckel RH, Lee LV, Bessac L, Pordy R, Letierce A, Cannon CP.

Atherosclerosis. 2019 Sep;288:85-93. doi: 10.1016/j.atherosclerosis.2019.07.008. Epub 2019 Jul 12.

41.

Primary generalized dystonia due to TOR1A ΔGAG mutation in an Indian family with intrafamilial clinical heterogeneity.

Giri S, Biswas A, Das SK, Ray K, Ray J.

Neurol India. 2019 May-Jun;67(3):872-875. doi: 10.4103/0028-3886.263172. No abstract available.

42.

Concurrent Exposure of Neutralizing and Non-neutralizing Epitopes on a Single HIV-1 Envelope Structure.

Ray K, Mengistu M, Orlandi C, Pazgier M, Lewis GK, DeVico AL.

Front Immunol. 2019 Jul 5;10:1512. doi: 10.3389/fimmu.2019.01512. eCollection 2019.

43.

HAstening the development of liver fibrosis.

Ray K.

Nat Rev Gastroenterol Hepatol. 2019 Aug;16(8):455. doi: 10.1038/s41575-019-0184-0. No abstract available.

PMID:
31273337
44.

Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial.

Ray KK, Colhoun HM, Szarek M, Baccara-Dinet M, Bhatt DL, Bittner VA, Budaj AJ, Diaz R, Goodman SG, Hanotin C, Harrington RA, Jukema JW, Loizeau V, Lopes RD, Moryusef A, Murin J, Pordy R, Ristic AD, Roe MT, Tuñón J, White HD, Zeiher AM, Schwartz GG, Steg PG; ODYSSEY OUTCOMES Committees and Investigators.

Lancet Diabetes Endocrinol. 2019 Aug;7(8):618-628. doi: 10.1016/S2213-8587(19)30158-5. Epub 2019 Jul 1. Erratum in: Lancet Diabetes Endocrinol. 2019 Jul 8;:. Lancet Diabetes Endocrinol. 2019 Sep;7(9):e21.

PMID:
31272931
45.

Dopamine β hydroxylase (DBH) polymorphisms do not contribute towards the clinical course of Wilson's disease in Indian patients.

Roy S, Ghosh S, Bhattacharya S, Saha A, Das SK, Gangopadhyay PK, Bavdekar A, Ray K, Sengupta M, Ray J.

J Gene Med. 2019 Sep;21(9):e3109. doi: 10.1002/jgm.3109. Epub 2019 Jul 23.

PMID:
31265749
46.

Kinetic Characterization of the C-H Activation Step for the Lipoxygenase from the Pathogenic Fungus Magnaporthe oryzae: Impact of N-Linked Glycosylation.

Kostenko A, Ray K, Iavarone AT, Offenbacher AR.

Biochemistry. 2019 Jul 23;58(29):3193-3203. doi: 10.1021/acs.biochem.9b00467. Epub 2019 Jul 10.

PMID:
31264852
47.

Lipoprotein(a) reductions from PCSK9 inhibition and major adverse cardiovascular events: Pooled analysis of alirocumab phase 3 trials.

Ray KK, Vallejo-Vaz AJ, Ginsberg HN, Davidson MH, Louie MJ, Bujas-Bobanovic M, Minini P, Eckel RH, Cannon CP.

Atherosclerosis. 2019 Sep;288:194-202. doi: 10.1016/j.atherosclerosis.2019.06.896. Epub 2019 Jun 8.

48.

Comparison of Lumbar Fusion for Back Pain and Opioid Use at County and Managed Care Hospitals.

Ghanchi H, Miulli D, Kashyap S, Toor H, Farr S, Ray K, Ashraf N, Rao S, Sweiss R, Beamer Y.

J Am Osteopath Assoc. 2019 Jul 1;119(7):419-427. doi: 10.7556/jaoa.2019.078.

PMID:
31233107
49.

A Temporal Study on Learning and Memory at High Altitude in Two Ethnic Groups.

Ray K, Kishore K, Vats P, Bhattacharyya D, Akunov A, Maripov A, Sarybaev A, Singh SB, Kumar B.

High Alt Med Biol. 2019 Sep;20(3):236-244. doi: 10.1089/ham.2018.0139. Epub 2019 Jun 17.

PMID:
31210541
50.

Transcriptomic profiles conducive to immune-mediated tumor rejection in human breast cancer skin metastases treated with Imiquimod.

Rozenblit M, Hendrickx W, Heguy A, Chiriboga L, Loomis C, Ray K, Darvishian F, Egeblad M, Demaria S, Marincola FM, Bedognetti D, Adams S.

Sci Rep. 2019 Jun 12;9(1):8572. doi: 10.1038/s41598-019-42784-9.

Supplemental Content

Support Center